Hepatic metastases from breast cancer

Arianna Rubino, Roberto Doci, Jean Claude Foteuh, Emanuela Morenghi, Susanna Fissi, Casimiro Giorgetta, Islam Abumalouh, Luca Di Tommaso, Leandro Gennari

Research output: Contribution to journalArticlepeer-review


The prognosis of patients with hepatic metastasis from breast cancer treated with systemic or regional chemotherapy is disappointing. When technically feasible, liver resection offers the best results. Eighteen patients out of 22 submitted to laparotomy underwent radical liver resection. Median follow-up from liver resection was 36 months. The median time interval between breast cancer diagnosis and disease recurrence was 35 months. Median disease-free survival and overall survival from liver resection were 66 and 74 months, respectively. Median survival time from breast cancer surgery was 88.5 months. Surgical treatment of liver metastases should be carried out on young and older patients alike when site of metastases is the liver alone. Neoadjuvant treatment and preoperative diagnostic laparoscopy should be planned in future experience.

Original languageEnglish
Pages (from-to)143-148
Number of pages6
JournalUpdates in Surgery
Issue number3-4
Publication statusPublished - 2010


  • Breast
  • Liver metastases
  • Liver resection
  • Treatment

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Hepatic metastases from breast cancer'. Together they form a unique fingerprint.

Cite this